Table 4.
Probability of Fertility Preservation Consultation by Sex
Consultation (n = 2932) |
||||||
---|---|---|---|---|---|---|
Female (n = 1704) |
Male (n = 1228) |
|||||
Coefficient | 95% CI | Significancea | Coefficient | 95% CI | Significancea | |
Insurance | ||||||
Private | Ref. | Ref. | ||||
Public | −0.0581 | −0.10 to −0.02 | ** | −0.1016 | −0.15 to −0.05 | *** |
Insured, NOS | 0.0046 | −0.05 to 0.06 | 0.0773 | 0.01 to 0.15 | * | |
Uninsured and unknown | −0.0422 | −0.10 to 0.01 | −0.0521 | −0.12 to 0.01 | ||
Diagnosis | ||||||
Osseous and chondromatous neoplasms and soft tissue sarcomas | Ref. | Ref. | ||||
Leukemia | 0.0789 | −0.03 to 0.19 | 0.2184 | 0.11 to 0.33 | *** | |
Lymphoma | 0.1089 | 0.01 to 0.21 | * | 0.1430 | 0.05 to 0.24 | ** |
CNS and other intracranial and intraspinal neoplasms | −0.0514 | −0.12 to 0.02 | −0.0562 | −0.14 to 0.02 | ||
Germ cell and trophoblastic neoplasms | −0.0785 | −0.20 to 0.04 | 0.1452 | 0.05 to 0.24 | ** | |
Melanoma and skin carcinomas | −0.0178 | −0.09 to 0.05 | −0.0912 | −0.17 to −0.01 | * | |
Carcinomas | 0.0238 | −0.04 to 0.09 | −0.0310 | −0.10 to 0.04 | ||
Misc. specified and unspecified malignant neoplasms | 0.0086 | −0.10 to 0.12 | −0.1013 | −0.19 to −0.01 | * | |
Oncologist | ||||||
Nonpediatric | Ref. | Ref. | ||||
Pediatric | 0.0324 | −0.04 to 0.11 | 0.0462 | −0.09 to 0.18 | ||
RUCA | ||||||
Urban | Ref. | Ref. | ||||
Large rural | −0.0075 | −0.05 to 0.03 | −0.0354 | −0.09 to 0.02 | ||
Small rural | −0.0152 | −0.06 to 0.03 | −0.0223 | −0.09 to 0.04 | ||
Isolated | −0.0129 | −0.06 to 0.04 | 0.0673 | −0.01 to 0.14 | ||
Unknown or international | 0.1389 | −0.16 to 0.43 | −0.0634 | −0.36 to 0.23 | ||
Race | ||||||
White | Ref. | Ref. | ||||
Non-White | 0.0502 | −0.02 to 0.12 | −0.0133 | −0.09 to 0.06 | ||
Unknown | 0.1422 | −0.11 to 0.39 | −0.1295 | −0.38 to 0.12 | ||
Ethnicity | ||||||
Non-Hispanic | Ref. | Ref. | ||||
Hispanic | −0.0525 | −0.12 to 0.02 | −0.0365 | −0.14 to 0.06 | ||
Unknown | −0.0970 | −0.32 to 0.12 | 0.1890 | −0.04 to 0.42 | ||
Age at diagnosis (years) | ||||||
15–19 | Ref. | Ref. | ||||
20–24 | 0.0008 | −0.07 to 0.07 | −0.0775 | −0.20 to 0.05 | ||
25–29 | 0.0160 | −0.05 to 0.08 | −0.0752 | −0.20 to 0.05 | ||
30–34 | −0.0045 | −0.07 to 0.06 | −0.2083 | −0.33 to −0.09 | ** | |
35–39 | −0.0430 | −0.10 to 0.02 | −0.2417 | −0.36 to −0.13 | *** | |
Year of diagnosis | ||||||
2008 | Ref. | Ref. | ||||
2009 | 0.0128 | −0.04 to 0.06 | 0.0267 | −0.07 to 0.12 | ||
2010 | 0.0519 | −0.01 to 0.11 | −0.0134 | −0.10 to 0.07 | ||
2011 | 0.0606 | −0.01 to 0.13 | 0.0276 | −0.06 to 0.12 | ||
2012 | 0.0839 | 0.01 to 0.16 | * | 0.0792 | −0.02 to 0.17 | |
2013 | 0.0834 | 0.01 to 0.15 | * | 0.0858 | −0.01 to 0.18 | |
2014 | 0.0475 | −0.02 to 0.11 | 0.1190 | 0.02 to 0.22 | * | |
2015 | 0.0356 | −0.03 to 0.10 | 0.1570 | 0.06 to 0.26 | ** | |
2016 | 0.1695 | 0.09 to 0.24 | *** | 0.0783 | −0.02 to 0.17 | |
2017 | 0.1598 | 0.08 to 0.23 | *** | 0.0685 | −0.03 to 0.16 |
Significance level corresponds to *p < 0.05, **p < 0.01, and ***p < 0.001.